Cargando…

Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders

OBJECTIVES: Delay in institution of appropriate mental healthcare is closely linked with attitudes, stigma, and availability of services, which further directs the help seeking pathways. This study was aimed to assess the pathway of care and attitudes toward psychotropic medications among patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nebhinani, Naresh, Pareek, Vrinda, Choudhary, Swati, Tripathi, Swapnil, Singh, Prerna, Kumar, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893934/
https://www.ncbi.nlm.nih.gov/pubmed/36743762
http://dx.doi.org/10.25259/JNRP-2021-11-39
_version_ 1784881629348495360
author Nebhinani, Naresh
Pareek, Vrinda
Choudhary, Swati
Tripathi, Swapnil
Singh, Prerna
Kumar, Manish
author_facet Nebhinani, Naresh
Pareek, Vrinda
Choudhary, Swati
Tripathi, Swapnil
Singh, Prerna
Kumar, Manish
author_sort Nebhinani, Naresh
collection PubMed
description OBJECTIVES: Delay in institution of appropriate mental healthcare is closely linked with attitudes, stigma, and availability of services, which further directs the help seeking pathways. This study was aimed to assess the pathway of care and attitudes toward psychotropic medications among patients with depressive disorder and psychotic disorders. MATERIALS AND METHODS: Eighty outpatients with depressive disorder and 40 patients with psychotic disorder were assessed in a tertiary care center for pathways to care and attitude toward psychotropics through Attitude toward Psychotropic Medications Questionnaire and Drug attitude inventory-10. RESULTS: The psychiatrist remained the most common first treatment contact (46% in depression and 62% in psychosis). Greater number of patients in psychotic disorder group had first treatment contact with faith healers or exorcist (17.5%), compared to depressive disorder (6.2%). Patients in depressive group had more favorable attitude toward psychotropics compared to psychosis group. Majority of patients had favorable attitude toward psychotropic medications, but they also had substantial misconceptions about side effects, utility, and need of taking lesser than prescribed doses. CONCLUSIONS: Although majority of patients had favorable attitude, they also had substantial misconceptions about medications. These issues need to be addressed for better delivery of comprehensive mental healthcare.
format Online
Article
Text
id pubmed-9893934
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-98939342023-02-03 Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders Nebhinani, Naresh Pareek, Vrinda Choudhary, Swati Tripathi, Swapnil Singh, Prerna Kumar, Manish J Neurosci Rural Pract Brief Report OBJECTIVES: Delay in institution of appropriate mental healthcare is closely linked with attitudes, stigma, and availability of services, which further directs the help seeking pathways. This study was aimed to assess the pathway of care and attitudes toward psychotropic medications among patients with depressive disorder and psychotic disorders. MATERIALS AND METHODS: Eighty outpatients with depressive disorder and 40 patients with psychotic disorder were assessed in a tertiary care center for pathways to care and attitude toward psychotropics through Attitude toward Psychotropic Medications Questionnaire and Drug attitude inventory-10. RESULTS: The psychiatrist remained the most common first treatment contact (46% in depression and 62% in psychosis). Greater number of patients in psychotic disorder group had first treatment contact with faith healers or exorcist (17.5%), compared to depressive disorder (6.2%). Patients in depressive group had more favorable attitude toward psychotropics compared to psychosis group. Majority of patients had favorable attitude toward psychotropic medications, but they also had substantial misconceptions about side effects, utility, and need of taking lesser than prescribed doses. CONCLUSIONS: Although majority of patients had favorable attitude, they also had substantial misconceptions about medications. These issues need to be addressed for better delivery of comprehensive mental healthcare. Scientific Scholar 2022-12-16 2022 /pmc/articles/PMC9893934/ /pubmed/36743762 http://dx.doi.org/10.25259/JNRP-2021-11-39 Text en © 2022 Published by Scientific Scholar on behalf of Journal of Neurosciences in Rural Practice https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Brief Report
Nebhinani, Naresh
Pareek, Vrinda
Choudhary, Swati
Tripathi, Swapnil
Singh, Prerna
Kumar, Manish
Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
title Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
title_full Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
title_fullStr Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
title_full_unstemmed Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
title_short Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
title_sort pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893934/
https://www.ncbi.nlm.nih.gov/pubmed/36743762
http://dx.doi.org/10.25259/JNRP-2021-11-39
work_keys_str_mv AT nebhinaninaresh pathwaysofcareandattitudestowardpsychotropicsinpatientswithdepressivedisordersandpsychoticdisorders
AT pareekvrinda pathwaysofcareandattitudestowardpsychotropicsinpatientswithdepressivedisordersandpsychoticdisorders
AT choudharyswati pathwaysofcareandattitudestowardpsychotropicsinpatientswithdepressivedisordersandpsychoticdisorders
AT tripathiswapnil pathwaysofcareandattitudestowardpsychotropicsinpatientswithdepressivedisordersandpsychoticdisorders
AT singhprerna pathwaysofcareandattitudestowardpsychotropicsinpatientswithdepressivedisordersandpsychoticdisorders
AT kumarmanish pathwaysofcareandattitudestowardpsychotropicsinpatientswithdepressivedisordersandpsychoticdisorders